ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial

Clinical trial NCT07264894 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07264894
Sponsor: Zhengzhou University
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Mantle Cell Lymphoma (MCL)

Start date: 2025-12-31
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.